The data was published in the centenary issue of the American Thoracic Society's 'Blue Journal and solidifies the need for individualised risk-benefit assessments when considering ICS treatments.
He spent much of his thirties alone in the mountains, carrying a tattered blue journal that he filled with sketches, scientific observations, and soulful writing.